Summary
- Current Price
- As of today, PRAX price is $298.95, down -3.71% on
- Current Price All-Time High
- PRAX price is currently -67.30% below its historical high of $914.27 set on
- Market Cap
- PRAX current market cap is $8B, up +777.06% over the past 365 days
- Revenue
- PRAX current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for PRAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Praxis Precision Medicines, Inc. |
| Ticker | NASDAQ: PRAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | praxismedicines.com |
| Employees | 116 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $298.95 | |
| Price, 1D Change | -3.71% | |
| Market Cap | $8B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.43 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | -100.00% | |
| EPS | -$13.48 | |
| EPS, 1Y Change | -31.99% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$13.48 | |
| EPS Estimate | -$13.94 | N/A |
| EPS Est. Change | -3.41% | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | $876.86K | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $298.95 | |
| Price Target | $575.00 | - |
| Price Tgt. Change | +92.34% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.10 | -$10.21 | -1.10% | |
| -$13.11 | -$13.48 | -2.80% | |
| -$13.94 | N/A | -3.41% | |
| -$9.29 | N/A | +31.03% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.46M | $8.55M | +487.48% | |
| $239.01K | $0.00 | -100.00% | |
| $876.86K | N/A | - | |
| $348.03M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +560.96% | |
| Price, 3Y | +1,303.52% | |
| Market Cap, 1Y | +777.06% | |
| Market Cap, 3Y | +4,472.87% | |
| Revenue, 1Y | -100.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -31.99% | |
| EPS, 3Y | +80.65% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $298.95 | |
| SMA 200 | $314.29 | |
| SMA 50 | $338.67 | |
| EMA 200 | $291.50 | |
| EMA 50 | $336.99 | |
| MACD | -$10.49 | |
| Beta | 0.43 | |
| ATR | $16.72 | |
| 14-Day RSI | 30.60 | |
| 10-Day Volatility | 27.54% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$13.48 | |
| Gross Profit | -$140.00K | |
| Gross Margin | - | |
| Operating Income | -$326.20M | |
| Operating Margin | - | |
| Net Income | -$303.27M | |
| Net Margin | - | |
| EBITDA | -$326.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.00 | |
| 10.22 | ||
| 10.22 | ||
| - | ||
| - | ||
| 81.61 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 6.22 | ||
| -20.07 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $878.14M | |
| $599.33M | ||
| $937.93M | ||
| $610.91M | ||
| $59.79M | ||
| $59.77M | ||
| Total Debt | $110.00K | |
| $110.00K | ||
| $24.63M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $303.27M | ||
| $326.06M | ||
| $140.00K | ||
| $0.00 | ||
| $140.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$249.07M | ||
| -$311.15M | ||
| $702.17M | ||
| Capex | $56.00K | |
| -$249.12M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Goldman Sachs | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Needham | → | |
| BTIG | → | |
| Goldman Sachs | ||
| Needham | → | |
| RBC Capital | ||
| Wedbush | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PRAX
FAQ
- What is the ticker symbol for Praxis Precision Medicines, Inc.?
- The ticker symbol for Praxis Precision Medicines, Inc. is NASDAQ:PRAX
- Does Praxis Precision Medicines, Inc. pay dividends?
- No, Praxis Precision Medicines, Inc. does not pay dividends
- What sector is Praxis Precision Medicines, Inc. in?
- Praxis Precision Medicines, Inc. is in the Healthcare sector
- What industry is Praxis Precision Medicines, Inc. in?
- Praxis Precision Medicines, Inc. is in the Biotechnology industry
- What country is Praxis Precision Medicines, Inc. based in?
- Praxis Precision Medicines, Inc. is headquartered in United States
- When did Praxis Precision Medicines, Inc. go public?
- Praxis Precision Medicines, Inc. initial public offering (IPO) was on October 16, 2020
- Is Praxis Precision Medicines, Inc. in the S&P 500?
- No, Praxis Precision Medicines, Inc. is not included in the S&P 500 index
- Is Praxis Precision Medicines, Inc. in the NASDAQ 100?
- No, Praxis Precision Medicines, Inc. is not included in the NASDAQ 100 index
- Is Praxis Precision Medicines, Inc. in the Dow Jones?
- No, Praxis Precision Medicines, Inc. is not included in the Dow Jones index
- When was Praxis Precision Medicines, Inc. last earnings report?
- Praxis Precision Medicines, Inc.'s most recent earnings report was on August 6, 2026
- When does Praxis Precision Medicines, Inc. report earnings?
- The next expected earnings date for Praxis Precision Medicines, Inc. is November 9, 2026
Data Sources & References
- PRAX Official Website praxismedicines.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1689548/000168954826000029/0001689548-26-000029-index.htm
- PRAX Profile on Yahoo Finance finance.yahoo.com/quote/PRAX
- PRAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prax
